Daily Dose of Vinpocetine: 15-30mg
Vinpocetine is a chemical that is obtained from a substance called vincamine, which is extracted from the periwinkle plant. The plant is very popular and is usually used to make gardens more attractive, but it is also used for its health benefits. One of its major health benefits is that it increases blood flow to selected parts of the brain. This improved blood flow to the brain can improve cognitive function, especially in certain areas. A study was conducted in patients who have suffered a stroke with mild cognitive deterioration. After Vinpocetine treatment, the patients experienced better cerebral blood flow and cognitive function. Unlike other parts of the body, like muscles, which can still function for a few minutes even without oxygen, the brain is not able to do “anaerobic metabolism”. Even just a brief delay in oxygen delivery to the brain can cause immediate damage to the cells. A healthy adult brain gets about one seventh of the heart’s blood output every minute, supplying it with enough oxygen and other nutrients it needs to function properly. Because Vinpocetine improves blood flow to the brain, it is used for enhancing memory and for preventing Alzheimer’s disease as well as other conditions that damage the learning, memory, and information processing skills as people get older.
Besides the brain, Vinpocetine can benefit our health in many other ways. Some of the more notable uses are its anti inflammatory effects, preventing hair loss, and reducing symptoms of vertigo. Studies have revealed that vinpocetine is very effective in reducing lung inflammation. Steroids are usually used to treat lung inflammation but Vinpocetine can give the same results without the dangerous side effects. Vinpocetine has also shown to be a safer treatment for hair loss compared to minoxidil, which has side effects such as chest pain and excessive low blood pressure. Because of its vasodilatory effects, vinpocetine can be effective in treating symtpoms of vertigo.
- Szilágyi G1, Nagy Z, Balkay L, Boros I, Emri M, Lehel S, Márián T, Molnár T, Szakáll S, Trón L, Bereczki D, Csiba L, Fekete I, Kerényi L, Galuska L, Varga J, Bönöczk P, Vas A, Gulyás B. Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study. J Neurol Sci. 2005 Mar 15;229-230:275-84. PMID: 15760651.
- Bereczki D1, Fekete I. Vinpocetine for acute ischaemic stroke. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000480. PMID: 18253980.
- Jovanović ZB1, Pavlović AM, Pekmezović T, Mijajlović M, Covicković NS. Transcranial Doppler assessment of cerebral vasomotor reactivity in evaluating the effects of vinpocetine in cerebral small vessel disease: a pilot study. Ideggyogy Sz. 2013 Jul 30;66(7-8):263-8. PMID: 23971358.